Take a look at the "keynote speakers":
John L. LaMattina, PhD, President Pfizer Global Research and Development, Pfizer
Jeffrey Elton, PhD, COO & Head of Strategy, Novartis Institutes for BioMedical Research
Jack H. Dean, Ph.D., Sc.D., D.A.B.T, Fellow A.T.S., President, US Science & Medical Affairs, Head, Global Preclinical Development, Sanofi-Aventis Group
Robert R. Ruffolo, Jr, PhD, President, Research & Development, Wyeth Pharmaceuticals, SVP, Wyeth Corporation
Lee Babiss, PhD, VP, Preclinical Research & Development, Roche
Jan M. Lundberg, PhD, EVP, Global Discovery Research, AstraZeneca
Brian Daniels, MD, Senior VIce President, Clinical Development, Bristol-Myers Squibb
Dr. Catherine Strader, EVP, Discovery Research, Schering-Plough Research Institute
Exactly! LOL.
http://www.drugdevelopmentsummit.com/
1 comment:
Pardon my ignorance - but why LOL? Aren't these the major players in pahram research? Or is it just that they have nothing in the pipeline?
Post a Comment